The chemotherapy infusion pumps market has seen considerable growth due to a variety of factors.
• The chemotherapy infusion pumps market has experienced solid growth in recent years. It will rise from $4.92 billion in 2024 to $5.24 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.5%.
The growth drivers include a shift to outpatient care, the increasing incidence of cancer, the development of healthcare infrastructure, an aging population, and rising healthcare expenditure.
The chemotherapy infusion pumps market is expected to maintain its strong growth trajectory in upcoming years.
• The chemotherapy infusion pumps market is projected to grow to $6.65 billion by 2029 at a CAGR of 6.1%.
The expansion of home healthcare, increased cancer incidence, and the adoption of home-based chemotherapy treatments drive this growth. Key trends include smart technology integration, customization in infusion pumps, and advancements in safety features.
The increasing prevalence of cancer is projected to drive the growth of the chemotherapy infusion pumps market. Cancer is a group of diseases marked by the uncontrolled growth and spread of abnormal cells. It is influenced by lifestyle factors, genetic predispositions, and environmental exposures such as smoking, radiation, and chemicals. Chemotherapy infusion pumps deliver precise doses of chemotherapy to patients, improving treatment efficiency and minimizing side effects. According to the World Health Organization, over 35 million new cancer cases are expected by 2050, which marks a 77% increase from 2022. As a result, the rising cancer incidence will contribute to the growth of the chemotherapy infusion pump market.
The chemotherapy infusion pumps market covered in this report is segmented –
1) By Type: Large Volume Pumps, Syringe Pump, Elastomeric Pumps, Ambulatory Infusion Pumps, Other Types
2) By Usage: Disposable, Reusable
3) By End User: Hospitals, Clinics, Home Care, Other End Users
Subsegments
1) By Large Volume Pumps: Traditional Large Volume Pumps, Volumetric Infusion Pumps
2) By Syringe Pump: Manual Syringe Pumps, Electronic Syringe Pumps
3) By Elastomeric Pumps: Disposable Elastomeric Pumps, Reusable Elastomeric Pumps
4) By Ambulatory Infusion Pumps: Disposable Ambulatory Infusion Pumps, Reusable Ambulatory Infusion Pumps
5) By Other Types: Smart Infusion Pumps, Patient-Controlled Analgesia (Pca) Pumps
In the chemotherapy infusion pumps market, companies are introducing advanced technologies like customizable infusion rates for multiple chemotherapy drugs, enabling more personalized and precise treatment plans. Customizable infusion rates allow healthcare providers to adjust the speed and dosage of chemotherapy drug delivery based on individual patient needs. For example, in May 2023, China-based Mindray launched the "Rhythm Dose" infusion mode in their BeneFusion i/u infusion pump series. This feature optimizes chemotherapy drug delivery by allowing healthcare professionals to administer continuous intravenous infusions of multiple chemotherapy drugs at varying rates, ensuring more tailored treatment plans for patients.
Major companies operating in the chemotherapy infusion pumps market are:
• Johnson & Johnson Services Inc.
• Medtronic plc
• Becton Dickinson and Company
• Baxter International Inc.
• Medline Industries LP
• B. Braun Holding GmbH & Co. KG
• Fresenius Kabi AG
• Grifols S.A.
• Terumo Corporation
• Nipro Corporation
• Smiths Group plc
• Moog Inc.
• Avanos Medical Inc.
• Halyard Health
• Vygon SAS
• Palex Medical SA
• Samtronic SA
• ICU Medical Inc.
• Pfm Medical Ag
• Zyno Medical LLC
• Leventon S.A.U.
• InfuTronix Solutions LLC
• Heka Healthcare
• PROMECON GmbH
North America was the largest region in the chemotherapy infusion pump market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chemotherapy infusion pumps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.